186.30MMarket Cap-2366P/E (TTM)
2.740High2.640Low281.86KVolume2.720Open2.800Pre Close753.08KTurnover0.44%Turnover RatioLossP/E (Static)70.30MShares4.91052wk High2.15P/B168.55MFloat Cap1.45052wk Low--Dividend TTM63.61MShs Float42.010Historical High--Div YieldTTM3.57%Amplitude1.240Historical Low2.671Avg Price1Lot Size
Codexis Stock Forum
Daily alerts recap 🔥🔥 200%+
Current watch ⚡️⚡️
$Pfizer(PFE.US)$$Abbott Laboratories(ABT.US)$$Capital One Financial(COF.US)$$Codexis(CDXS.US)$$Sigmatron International(SGMA.US)$$Guardforce AI(GFAI.US)$$22nd Century(XXII.US)$$Quoin Pharmaceuticals(QNRX.US)$$Digital World Acquisition Corp(DWAC.US)$$Rivian Automotive(RIVN.US)$
TOP WATCH AH + 7/21 ⚡️⚡️
ColumnsToday's pre-market stock movers: PINS, C, PNC, RIO and more
• $Vertical Aerospace(EVTL.US)$ +46.2% (FLYINGGROUP, one of Europe’s leading business jet operators, has conditionally pre-ordered up to 50 VX4 aircraft)
• $Pinterest(PINS.US)$ +15% (activist Elliott Mgmt has built a 9+% stake, according to WSJ)
• $Citigroup(C.US)$ +4.6% (Citigroup Q2 EPS $2.19 Beats $1.69 Estimate, Sales $19.60B Beat $18.12B Estimate)
• $Red Robin(RRGB.US)$ +3.2% (names new CEO)
• $NexGen Energy(NXE.US)$ +2...
ColumnsTop upgrades and downgrades on 3/31
• $Baker Hughes(BKR.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $43
• $CDW Corp(CDW.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $214 (from $201)
• $Core & Main(CNM.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $Five Below(FIVE.US)$ : Citigroup Upgrades to Buy from Neutral - PT $205 (from $176)
• $Vector(VGR.US)$ : Barclays Uprages to Overweight from Equal Weight - PT $16 (from ...
ARK's Buys and Sells (December 21)
ARK's Buys
$Niu Technologies(NIU.US)$$Robinhood(HOOD.US)$$Coinbase(COIN.US)$$DraftKings(DKNG.US)$$UiPath(PATH.US)$
ARK's Sells
$Iridium Communications(IRDM.US)$$Codexis(CDXS.US)$$Ionis Pharmaceuticals(IONS.US)$$10x Genomics(TXG.US)$$Unity Software(U.US)$$Zillow-C(Z.US)$
ARK update
Sells $Farfetch(FTCH.US)$$Opendoor Technologies(OPEN.US)$$Meta Platforms(FB.US)$$Codexis(CDXS.US)$$Tesla(TSLA.US)$
Buys $Invitae(NVTA.US)$$StoneCo(STNE.US)$$Niu Technologies(NIU.US)$$Roku Inc(ROKU.US)$
Pfizer disclosed purchase orders totaling $29 million.
Codexis said the orders are for the delivery of the company's enzyme products, which will be used in the production of Pfizer's Novel Coronavirus 19 drug candidate PF-07321332.
On June 17 and August 25, CDXS announced receipt of purchase orders for the production of unnamed active pharmaceutica intermediates in drug candidates.
In September, Pfizer announced the initiation of a Phase 2/3 clinical study to evaluate the efficacy of PF-07321332 in combination with low-dose ritonavir for the prevention of Novel Coronavirus-19.
CDXS
No comment yet